Tela Bio, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$10Mgeneral payments (2019-2025)
$13Kresearch payments (2019-2025)
8,970clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $597K
2020 $447K
2021 $1.3M
2022 $2.0M
2023 $2.1M
2024 $2.1M
2025 $1.8M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Surgery $5.2M
Plastic Surgery $2.1M
Plastic and Reconstructive Surgery $1.1M
Surgical Critical Care $948K
Colon & Rectal Surgery $95K
Trauma Surgery $89K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Paul Szotek Indianapolis, IN Surgery $2,363,082.91
Samir Awad Houston, TX Surgical Critical Care $855,894.58
Rahm Nazerali Palo Alto, CA Plastic Surgery $545,560.27
Michael Sawyer Lawton, OK $483,176.11
Jorge Florin Winter Garden, FL Surgery $413,520.27
Howard Langstein Rochester, NY Plastic and Reconstructive Surgery $332,316.26
George Denoto Manhasset, NY Surgery $331,512.39
Evan Katzel Philadelphia, PA Plastic Surgery $325,968.13
Salvatore Pacella San Diego, CA Plastic Surgery $267,402.42
Charles Butler Houston, TX Plastic and Reconstructive Surgery $179,698.83

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.